Development of European Regulations on Radiopharmaceuticals

  • Knud Kristensen


Radioactive substances used for diagnosis and therapy in nuclear medicine and research were recognized as drugs in some European countries more than 20 years ago, while in other countries this will not happen until the first of January 1992, when European Community (EEC) directives require national regulations to be established. Radiation protection regulations however were introduced in most countries in the fifties or sixties covering both radiation protection of workers and the general population including patients.


International Atomic Energy Agency Medicinal Product Radiation Protection Marketing Authorization Good Manufacture Practice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Good Practice in the Manufacture of Radiopharmaceuticals. A proposal put forward by a group of Pharmacists from the Nordic countries. Arch Pharm Chem 78: 1002–1009, 1971.Google Scholar
  2. 2.
    Pharmacopoea Nordica, Copenhagen 1963.Google Scholar
  3. 3.
    Radiopharmaceuticals, Drug Applications. Nordic Guidelines. Nordic Council on Medicines publication 20, Uppsala 1988 ISBN 91–86432–19–2.Google Scholar
  4. 4.
    Radiopharmacy. Preparation and Control of radiopharmaceuticals in hospitals. Nordic Council on Medicines publication 26, Uppsala 1989 ISBN 91–86432–25–7.Google Scholar
  5. 5.
    Council of Europe, European Pharmacopeia 2nd Edition, Parts I-II. Maisonneuve S.A. (1980–1989).Google Scholar
  6. 6.
    The Rules Governing Medicinal Products in the European Community vol 1: The rules governing medicinal products for human use in the EEC, EEC Bruxelles 1989, ISBN 95–825–9563–3.Google Scholar
  7. 7.
    The Rules Governing Medicinal Products in the European Community, vol III: Guidelines on Quality, Safety and efficacy of medicinal products for human use, EEC Bruxelles 1989, ISBN 95–825–9619–2.Google Scholar
  8. 8.
    Council directive of 3 May 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC and laying down additional pervisions for radiopharmaceuticals 89/343/EEC.Google Scholar
  9. 9.
    The Rules Governing Medicinal Products in the European Community vol IV: Guide to Good Manufacturing practice for medicinal products EEC Bruxelles 1989 ISBN 92–825–9572–2.Google Scholar
  10. 10.
    EFTA, Basic Standards of Good Manufacturing Practice for Pharmaceutical Products, Document PH 3/83 (Revised version), EFTA Secretariate, Geneva (1983).Google Scholar
  11. 11.
    Institute of Physical Sciences in Medicine: Hospital Radiopharmacy. Principles and Practice. Report no.56, London, 1988.Google Scholar
  12. 12.
    Kristensen, K., Preparation and Control of Radiopharmaceuticals in Hospitals, IAEA, Vienna, (1979).Google Scholar
  13. 13.
    C.R. Lazarus: Training and Education in Kristensen K. and Norbygaard E. (editors), Safety and efficacy of radiopharmaceuticals, Martinus Nijhoff Publishers (1987).Google Scholar
  14. 14.
    European Association of Nuclear Medicine, Task Group on Radiopharmaceuticals and The Council of Europe: Training of radiopharmacists and radiochemists, to be published European Journal of Nuclear Medicine.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Knud Kristensen
    • 1
  1. 1.The Isotope-PharmacyThe National Board of HealthCopenhagen (Brønshøj)Denmark

Personalised recommendations